Cargando…
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400146/ https://www.ncbi.nlm.nih.gov/pubmed/30853998 http://dx.doi.org/10.7573/dic.212569 |
| _version_ | 1783399899865284608 |
|---|---|
| author | Accurso, Vincenzo Santoro, Marco Mancuso, Salvatrice Napolitano, Marisante Di Piazza, Florinda Russo, Antonio Siragusa, Sergio Mario |
| author_facet | Accurso, Vincenzo Santoro, Marco Mancuso, Salvatrice Napolitano, Marisante Di Piazza, Florinda Russo, Antonio Siragusa, Sergio Mario |
| author_sort | Accurso, Vincenzo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6400146 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioExcel Publishing Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64001462019-03-08 Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system Accurso, Vincenzo Santoro, Marco Mancuso, Salvatrice Napolitano, Marisante Di Piazza, Florinda Russo, Antonio Siragusa, Sergio Mario Drugs Context Case Report BioExcel Publishing Ltd 2019-03-04 /pmc/articles/PMC6400146/ /pubmed/30853998 http://dx.doi.org/10.7573/dic.212569 Text en Copyright © 2019 Accurso V, Santoro M, Mancuso S, Napolitano M, Di Piazza F, Russo A, Siragusa SM. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
| spellingShingle | Case Report Accurso, Vincenzo Santoro, Marco Mancuso, Salvatrice Napolitano, Marisante Di Piazza, Florinda Russo, Antonio Siragusa, Sergio Mario Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title | Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title_full | Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title_fullStr | Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title_full_unstemmed | Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title_short | Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| title_sort | efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400146/ https://www.ncbi.nlm.nih.gov/pubmed/30853998 http://dx.doi.org/10.7573/dic.212569 |
| work_keys_str_mv | AT accursovincenzo efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT santoromarco efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT mancusosalvatrice efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT napolitanomarisante efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT dipiazzaflorinda efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT russoantonio efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem AT siragusasergiomario efficacyofruxolitinibretreatmentinapatientwithhighriskmyelofibrosisusingtheinternationalprognosticscoringsystem |